T32 Training Program
T32 Training Grant: Kidney Disease & Inflammation
Mark D. Okusa, M.D., FASN
Division Chief and CIIR Director
Division of Nephrology
P.O. Box 800133
UVA Health System
Charlottesville, VA, 22908
The Nephrology Fellowship Training Program at the University of Virginia offers an interdisciplinary research program targeted to highly-motivated, academically-oriented postdoctoral fellows. The program includes basic translational research and patient-oriented clinical research and aims to produce graduates who will contribute to a new generation of academic nephrologists and renal investigators prepared to address the growing problem of kidney disease. We value and encourage applicants from diverse backgrounds.
This new program focuses on Kidney Disease and Inflammation, bringing together outstanding clinician and basic science investigators with a track record of mentorship from Departments and Centers including: Medicine, Pediatrics, Pharmacology, Microbiology, Pathology, Biomedical Engineering, Molecular Physiology and Biophysics, the Cardiovascular Research Center, Center for Cell Signaling, Beirne Carter Center of Immunology and the Center for Public Health Genomics.
Training is provided in fundamental and leading edge disciplines including molecular, cellular, transgenic technologies, immunology, functional genomics and novel imaging technologies. The patient-oriented clinical research program provides training in clinical investigation, epidemiology, and biostatistics.
Trainees with M.D. degrees pursue a program consisting of one year of clinical training, not supported by the grant, and two years of research training funded by the grant. Ph.D. applicants are required to have prior research experience and outstanding references. All trainees are required to attend specific courses addressing research methodologies, experimental design, research integrity, ethics, and faculty development.
Our Visiting Professor Program brings world class scientists to UVA to interact with our trainees and faculty.